Skip to content

RTA Retinal Thickness Analyzer Modification

by Talia Technology, Ltd.

510(k) K000731

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK000731 Date31 Mar 2000ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Modification to Rta Retinal Thickness Analyzer
510(k) Number
FDA Product Code
HLI
FDA applicant
Talia Technology , Ltd.
Device Class
Class II
Regulation
21 CFR Part 886.1570
Advisory Committee
Ophthalmic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The RTA Retinal Thickness Analyzer Modification is an AC-powered ophthalmic device designed for retinal imaging. It employs illumination and optical systems to assess retinal thickness and examine ocular media, including the cornea, aqueous, lens, and vitreous, enabling detailed in vivo retinal analysis.

This modification is intended for use in clinical ophthalmology settings and is classified as a Class II device under FDA regulations. Supplied as a reusable instrument, it requires proper calibration and maintenance. The device holds an FDA 510(k) clearance (K000731) for modifications, ensuring compliance with regulatory standards for ophthalmic diagnostic equipment.

Other devices from Talia Technology, Ltd.

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is this device single-use or reusable, and what maintenance is required?

    The MODIFICATION TO RTA RETINAL THICKNESS ANALYZER is designed as a reusable instrument and requires proper calibration and maintenance to ensure accurate retinal imaging and ocular media assessment. Since it is classified as a reusable Class II device under FDA regulations, adherence to manufacturer guidelines for cleaning, sterilization (if applicable), and periodic servicing is essential for reliable performance and compliance with regulatory standards.

  • What types of ocular structures can this device analyze, and how does it work?

    This device uses illumination and optical systems to assess retinal thickness and examine multiple ocular media, including the cornea, aqueous, lens, and vitreous. It performs in vivo retinal analysis, allowing clinicians to evaluate structural details of the eye without invasive procedures. The technology relies on precise imaging to support diagnostic decisions in clinical ophthalmology.

  • How is this device regulated, and what does the FDA clearance cover?

    The MODIFICATION TO RTA RETINAL THICKNESS ANALYZER holds an FDA 510(k) clearance (K000731) under the Special 510(k) Review Program, classified as Substantially Equivalent to predicate devices. This clearance confirms compliance with FDA standards for ophthalmic diagnostic equipment, specifically for modifications to existing retinal thickness analyzers. The regulatory route ensures the device meets safety and performance requirements for clinical ophthalmology use.

  • Is this device AC-powered, and what clinical settings is it intended for?

    Yes, the device is AC-powered and is intended for use in clinical ophthalmology settings. It is designed for professional use in environments where retinal imaging and ocular media assessment are performed, such as hospitals, eye clinics, or specialized ophthalmology practices. The modification ensures compatibility with existing RTA systems while maintaining regulatory compliance.